Cumberland Pharmaceuticals Inc
Nasdaq · Healthcare · Pharmaceutical Preparations · Nashville,, TN
CPIX chart
What traders are saying about $CPIX
Latest postsCumberland Pharmaceuticals Inc news
- Cumberland Pharmaceuticals Inc. (CPIX) Investigation: Bronstein
The National Law Review ·
- Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Cumberland Pharmaceuticals (CPIX)
ACCESS Newswire ·
- CPIX Investors Have Opportunity to Join Cumberland Pharmaceuticals Inc. Fraud Investigation with SBS Law
Business Wire ·
- Cumberland Pharmaceuticals (CPIX.US) will release its financial report after the market close on November 10.
Moomoo ·
- CUMBERLAND PHARMACEUTICALS TO ANNOUNCE COMPANY UPDATE & Q3 2026 FINANCIAL RESULTS
Yahoo Finance ·
- A 4:30 p.m. Eastern call will discuss Cumberland's third-quarter results Nov. 10.
Stock Titan ·
- Cumberland Pharmaceuticals Begins Rolling FDA NDA for Dyscorban in Duchenne Cardiomyopathy
marketbeat.com ·
- CUMBERLAND PHARMACEUTICALS ANNOUNCES PLANS TO FILE NEW DRUG APPLICATION FOR IFETROBAN DMD PROGRAM
Yahoo Finance ·
- Cumberland Pharmaceuticals stock tumbles on trial results
Yahoo Finance ·
- Cumberland Pharmaceuticals Announces ASSIST-SSc Trial Top-Line Results
Yahoo Finance ·
- CUMBERLAND PHARMACEUTICALS PROVIDES UPDATED WEBCAST REGISTRATION LINK FOR IFETROBAN DMD PROGRAM CALL
Yahoo Finance ·
- CUMBERLAND PHARMACEUTICALS ANNOUNCES NATIONAL CALL TO PRESENT AN UPDATE ON ITS IFETROBAN DMD PROGRAM
Yahoo Finance ·
Cumberland Pharmaceuticals Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $44.5M | $37.9M | $39.6M | $42.0M |
| Net income | -$2.8M | -$6.5M | -$6.3M | -$5.6M |
| Diluted EPS | $-0.19 | $-0.46 | $-0.44 | $-0.38 |
| Total assets (year end) | $76.8M | $75.6M | $81.8M | $92.9M |
| Cash and equivalents (year end) | $11.4M | $18.0M | $18.3M | $19.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Cumberland Pharmaceuticals Inc
- Ticker
- CPIX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Nashville,, TN
- Incorporated in
- TN
- Fiscal year end
- December 31
- SEC CIK
- 1087294
Frequently asked questions
What exchange is Cumberland Pharmaceuticals Inc listed on?
Cumberland Pharmaceuticals Inc trades on the Nasdaq under the ticker symbol CPIX.
What industry is Cumberland Pharmaceuticals Inc in?
Cumberland Pharmaceuticals Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Cumberland Pharmaceuticals Inc headquartered?
Cumberland Pharmaceuticals Inc's business address on file with the SEC is in Nashville,, TN.
When does Cumberland Pharmaceuticals Inc's fiscal year end?
Cumberland Pharmaceuticals Inc's fiscal year ends on December 31.
How much revenue did Cumberland Pharmaceuticals Inc report?
Cumberland Pharmaceuticals Inc reported $44.5M in revenue for calendar year 2025, according to its SEC filings.